Cargando…

Insights into the Steps of Breast Cancer–Brain Metastases Development: Tumor Cell Interactions with the Blood–Brain Barrier

Brain metastases (BM) represent a growing problem for breast cancer (BC) patients. Recent studies have demonstrated a strong impact of the BC molecular subtype on the incidence of BM development. This study explores the interaction between BC cells of different molecular subtypes and the blood–brain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamester, Fabienne, Stürken, Christine, Saygi, Ceren, Qi, Minyue, Legler, Karen, Gorzelanny, Christian, Robador, José R., Schmalfeldt, Barbara, Laakmann, Elena, Müller, Volkmar, Witzel, Isabell, Oliveira-Ferrer, Leticia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836543/ https://www.ncbi.nlm.nih.gov/pubmed/35163822 http://dx.doi.org/10.3390/ijms23031900

Ejemplares similares

Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer
por: Hamester, Fabienne, et al.
Publicado: (2022)

Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis
por: Kempska, Joanna, et al.
Publicado: (2023)

Breast cancer brain metastases: biology and new clinical perspectives
por: Witzel, Isabell, et al.
Publicado: (2016)

Molecular characteristics and tumorigenicity of ascites‐derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer
por: Ding, Yi, et al.
Publicado: (2021)

Brain Metastasis in Breast Cancer Patients—Need for Improvement
por: Witzel, Isabell, et al.
Publicado: (2020)

Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancer
por: Volk, Annabelle, et al.
Publicado: (2023)

The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients
por: Reimer, Francesca, et al.
Publicado: (2023)

Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry
por: Laakmann, Elena, et al.
Publicado: (2016)

Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer
por: Legler, Karen, et al.
Publicado: (2018)

Molecular Mechanisms Associated with Brain Metastases in HER2-Positive and Triple Negative Breast Cancers
por: Bryan, Sarah, et al.
Publicado: (2021)

Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation
por: Hamester, Fabienne, et al.
Publicado: (2019)

Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain Metastases
por: Laakmann, Elena, et al.
Publicado: (2020)

Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2020)

Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores
por: Riecke, Kerstin, et al.
Publicado: (2021)

Ovarian Cancer-Cell Pericellular Hyaluronan Deposition Negatively Impacts Prognosis of Ovarian Cancer Patients
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2022)

VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients
por: Kuerti, Sascha, et al.
Publicado: (2017)

Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry
por: Laakmann, E., et al.
Publicado: (2022)

Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry
por: Riecke, K., et al.
Publicado: (2023)

Role of the Blood-Brain Barrier in the Formation of Brain Metastases
por: Wilhelm, Imola, et al.
Publicado: (2013)

Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer
por: Witzel, Isabell, et al.
Publicado: (2014)

VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients
por: Ding, Yi, et al.
Publicado: (2022)

ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium
por: Münsterberg, Justine, et al.
Publicado: (2020)

Blood–brain barrier and brain structural changes in lung cancer patients with non-brain metastases
por: Zhang, Da-Fu, et al.
Publicado: (2022)

How to Make Anticancer Drugs Cross the Blood–Brain Barrier to Treat Brain Metastases
por: Angeli, Eurydice, et al.
Publicado: (2019)

Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases
por: Bernatz, Simon, et al.
Publicado: (2019)

Behind Brain Metastases Formation: Cellular and Molecular Alterations and Blood–Brain Barrier Disruption
por: Godinho-Pereira, Joana, et al.
Publicado: (2021)

Navigating the Blood–Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases
por: Terceiro, Lucas E. L., et al.
Publicado: (2023)

Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases
por: Puttemans, Janik, et al.
Publicado: (2019)

Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases
por: Wikman, Harriet, et al.
Publicado: (2012)

Evaluation of a program for routine implementation of shared decision-making in cancer care: study protocol of a stepped wedge cluster randomized trial
por: Scholl, Isabelle, et al.
Publicado: (2018)

Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2018)

Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto
por: Laakmann, Elena, et al.
Publicado: (2019)

Brain metastases
por: Plowman, Nick
Publicado: (2012)

Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer brain metastases
por: Uzunalli, Gozde, et al.
Publicado: (2019)

Blood–Brain Barrier, Cell Junctions, and Tumor Microenvironment in Brain Metastases, the Biological Prospects and Dilemma in Therapies
por: Guan, Zhiyuan, et al.
Publicado: (2021)

BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer
por: Elazezy, Maha, et al.
Publicado: (2021)

Evaluation of a program for routine implementation of shared decision-making in cancer care: results of a stepped wedge cluster randomized trial
por: Scholl, Isabelle, et al.
Publicado: (2021)

Dysfunction of the Blood-Brain Barrier—A Key Step in Neurodegeneration and Dementia
por: Noe, Christian R., et al.
Publicado: (2020)

Involvement of platelet-derived VWF in metastatic growth of melanoma in the brain
por: Robador, Jose R, et al.
Publicado: (2021)

Adaptation and qualitative evaluation of encounter decision aids in breast cancer care
por: Hahlweg, Pola, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mitunt6vqd39noqb7j05gbiuk6